NEW YORK — Drugstore chain CVS Caremark Corp. says it has agreed to buy the drug infusion business Coram LLC, a unit of Apria Healthcare Group Inc., for $2.1 billion.
Coram, which is based in Denver, provides customers with medication and nutrition that is administered through a vein. The medication can be delivered to a customer's home, clinic or doctor's office.
CVS expects the deal to close by the end of the first quarter of 2014.
CVS expects Coram to generate revenue of about $1.4 billion in the first year after the deal closes and add earnings of between 3 cents per share and 5 cents per share in 2015.
Apria Healthcare Group Inc., Coram's parent company, is owned by investment firm The Blackstone Group LP.
Anda sedang membaca artikel tentang
CVS Caremark to buy Coram for $2.1 billion
Dengan url
http://wartegjokowi.blogspot.com/2013/11/cvs-caremark-to-buy-coram-for-21-billion.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
CVS Caremark to buy Coram for $2.1 billion
namun jangan lupa untuk meletakkan link
CVS Caremark to buy Coram for $2.1 billion
sebagai sumbernya
0 komentar:
Posting Komentar